A “cross-Nordic RWE study” includes an analysis of data from multiple Nordic countries. In 2022, Quantify published 8 papers, based on EMPRISE, BISCUITS, NORDSTAR and the ATTR-CM study, providing important evidence on Nordic-wide comparative effectiveness, treatment patterns and unmet needs, in various disease areas. In contrast to single country studies, cross-Nordic research provides better generalizability and can identify important Nordic differences in routine clinical care, in addition to increasing sample size. We would like to say a big thank you to our many collaborators for choosing to work with Quantify on these exciting projects!
“Over the past years, Quantify has acquired industry-leading expertise in the access and analysis of data from all Nordic countries and we are very happy to finally be able to share the outcome of these exciting projects together with our clients,” says Emilie Toresson Grip, Director and Head of RWE and Analytics.
Additional Nordic publications are in the submission stage and many other cross-Nordic projects are ongoing, so stay tuned for more Nordic RWE updates!
For more information on our publications or RWE services, please visit https://lnkd.in/dqfYrUxF, or contact info@quantifyresearch.com.